Our data show that the levels of RET receptor expression were significantly higher on all lymphocyte subsets (B, T and NK cells) of HSCR patients carrying a putative pathogenic variant of RET gene compared to those of HSCR patients not carrying any mutation in RET gene. This evidence concerns the gene RET and Hirschsprung disease.